A carregar...
(1)H-NMR and (13)C-NMR dataset for some oxidative metabolites of CRA13 and their analogs
CRA13 (CB-13; SAB-378) is a dual CB(1)R/CB(2)R agonist cannabinoid agent developed by Novartis Pharma. Upon administration, it undergoes metabolism to oxidative metabolites. Herein, the (1)H-NMR and (13)C-NMR dataset of some oxidative metabolites and analogs thereof are presented for further analysi...
Na minha lista:
| Publicado no: | Data Brief |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6198130/ https://ncbi.nlm.nih.gov/pubmed/30364648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2018.09.069 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|